Sophia Antipolis 26 April 2018. Tips and tricks for patients living with acute and chronic heart failure1 will be among the topics discussed at the annual congress of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in Vienna, Austria, 26 to 29 May. The full scientific programme is now available for Heart Failure 2018 and the World Congress on Acute Heart Failure, which will be held concurrently at Vienna’s Messe Wien.
“Patients with heart failure want to know if they can drive, climb mountains, travel long distances,” said Professor Mitja Lainscak, scientific chairperson of the congress. “They ask about consumption of salt, alcohol, coffee, and chocolate, about smoking, and managing psychosocial distress. One of the sessions will be devoted to providing answers to these frequently asked practical and important questions.”
Reflecting the rich cultural history of Vienna, the theme for this year’s congress is ‘classical repertoire, modern instruments’. “Heart failure is a ‘classical’ condition that we can manage with ‘modern’ methods,” said Professor Lainscak.
One example is promoting alternatives to conventional exercise and physical activity.2 Exercise reduces the risk of early death in patients with heart failure, but adherence is low. Patients can be motivated with new approaches to the ancient practices of yoga and tai chi, or by ‘exergaming’ using video games, for example, that involve physical exercise. Technical alternatives to physical activity include devices for whole body vibration or transcutaneous electrical nerve stimulation for patients unable to exercise due to severe heart failure, or as a bridge to exercise in those with acute heart failure.
Novel drugs in acute and chronic heart failure will be highlighted in a dedicated session.3 Potassium binding drugs, for example, prevent hyperkalaemia which is a deadly complication of some heart failure medications. Professor Lainscak said: “We are adopting a strategy similar to that in oncology whereby we give one drug so that we can administer a second drug with proven efficacy for heart failure patients.”
Heart failure therapies on the horizon are the focus of a basic science session in which leaders in the field will discuss how to fix mutated genes, target epigenetic mechanisms, target non-coding RNAs, and use induced pluripotent stem cells.4
Four debates will be held on controversial issues including whether coronary revascularisation provides clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure; and whether catheter ablation is superior to drugs for treating patients with atrial fibrillation and heart failure.5 “Devices appear to have more potential than drugs for treating heart failure and there are many more devices in development versus very few drugs,” said Professor Lainscak.
Epidemiological data on heart failure from Austria, Germany, Hungary, Switzerland, the Czech Republic, Slovakia, and Slovenia6 will be presented, showing how many patients have heart failure in central Europe and the differences between countries. “This kind of data is critical to determine the finances and systems needed to tackle heart failure and to engage the necessary political support to put them in place,” noted Professor Lainscak.
More than 50 years since the world’s first heart transplant, one of the sessions at the congress will reveal the latest advances in immunosuppression. Professor Sir Magdi Yacoub will deliver a lecture on the changing face of heart transplantation.7
During ‘Off the record’ sessions at the congress, Professors Eugene Braunwald, Marc Pfeffer, Barbara Casadei, and Walter Paulus will present their views on heart failure and take part in discussions on wide-ranging issues in heart failure and their personal careers.8
1Tips and tricks for daily living with heart failure
2Alternative ways to increase physical activity
3Novel drugs in heart failure
4New heart failure therapies at the horizon
6Heart failure as a major local and global challenge in the 21st century
7Hearts of gold: 50 years of heart transplantation
8Off the record sessions
Authors: ESC Press Office
Tel: +33 (0)4 89 87 24 83
Mob: +33 (0)6 24 71 28 96
About Heart Failure 2018 and the World Congress on Acute Heart Failure
Heart Failure and the World Congress on Acute Heart Failure are annual congresses of the Heart Failure Association (HFA) of the ESC.
About the Heart Failure Association
The Heart Failure Association (HFA) is a branch of the ESC. Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
About the European Society of Cardiology
The European Society of Cardiology brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
Information for journalists attending Heart Failure 2018
Heart Failure 2018 and the World Congress on Acute Heart Failure will be held 26 to 29 May at the Messe Wien in Vienna, Austria. Read the full scientific programme.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved